Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation
- PMID: 29121521
- DOI: 10.1016/j.scr.2017.10.026
Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation
Abstract
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most prevalent monogenic kidney disorder leading to kidney failure. We generated induced pluripotent stem cells (iPSCs) from a 37-year-old man carrying a PKD1 Q533X mutation who suffered from kidney failure and a myocardial infarction. The iPSCs were reprogrammed from the patient's peripheral blood mononuclear cells using the Sendai virus system, and were confirmed to possess the specific PKD1 Q533X mutation and normal karyotype. Pluripotency was confirmed using in vitro and in vivo assays. This iPSC line will be useful for studying the mechanisms driving the complicated pathophysiology of ADPKD.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.Stem Cell Res. 2017 Dec;25:38-41. doi: 10.1016/j.scr.2017.10.005. Epub 2017 Oct 10. Stem Cell Res. 2017. PMID: 29055226
-
Generation of an induced pluripotent stem cell line (ZSPHARi002-A) from a patient with autosomal dominant polycystic kidney disease carrying a heterozygous PKD1 mutation.Stem Cell Res. 2025 Feb;82:103643. doi: 10.1016/j.scr.2024.103643. Epub 2024 Dec 24. Stem Cell Res. 2025. PMID: 39742629
-
Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.Stem Cell Res Ther. 2017 Sep 19;8(1):196. doi: 10.1186/s13287-017-0645-8. Stem Cell Res Ther. 2017. PMID: 28927462 Free PMC article.
-
Genetic Mechanisms of ADPKD.Adv Exp Med Biol. 2016;933:13-22. doi: 10.1007/978-981-10-2041-4_2. Adv Exp Med Biol. 2016. PMID: 27730431 Review.
-
Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.Hum Mutat. 2014 Dec;35(12):1393-406. doi: 10.1002/humu.22708. Hum Mutat. 2014. PMID: 25263802 Review.
Cited by
-
Review on kidney diseases: types, treatment and potential of stem cell therapy.Ren Replace Ther. 2023;9(1):21. doi: 10.1186/s41100-023-00475-2. Epub 2023 Apr 27. Ren Replace Ther. 2023. PMID: 37131920 Free PMC article. Review.
-
Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.EBioMedicine. 2019 Feb;40:675-684. doi: 10.1016/j.ebiom.2019.01.011. Epub 2019 Jan 11. EBioMedicine. 2019. PMID: 30639418 Free PMC article.
-
Opportunities and Challenges of Human IPSC Technology in Kidney Disease Research.Biomedicines. 2022 Dec 12;10(12):3232. doi: 10.3390/biomedicines10123232. Biomedicines. 2022. PMID: 36551987 Free PMC article. Review.
-
Engineering approaches for cardiac organoid formation and their characterization.Transl Res. 2022 Dec;250:46-67. doi: 10.1016/j.trsl.2022.08.009. Epub 2022 Aug 19. Transl Res. 2022. PMID: 35995380 Free PMC article. Review.
-
Human iPSC banking: barriers and opportunities.J Biomed Sci. 2019 Oct 28;26(1):87. doi: 10.1186/s12929-019-0578-x. J Biomed Sci. 2019. PMID: 31660969 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials